96 related articles for article (PubMed ID: 6541399)
1. Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health.
Wray SR; Melville GN; Wenger T; Louden D
West Indian Med J; 1984 Jun; 33(2):106-16. PubMed ID: 6541399
[No Abstract] [Full Text] [Related]
2. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
van Ree JM; Igarashi J; Király I
NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632
[TBL] [Abstract][Full Text] [Related]
3. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
Crawley JH
Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
[TBL] [Abstract][Full Text] [Related]
4. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
Vaccarino FJ; Rankin J
Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
[TBL] [Abstract][Full Text] [Related]
5. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi.
Kelly PH; Roberts DC
Pharmacol Biochem Behav; 1983 Jul; 19(1):137-43. PubMed ID: 6413984
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat.
Van den Bos R; Cools AR; Ogren SO
Acta Physiol Scand; 1990 Mar; 138(3):423-4. PubMed ID: 2158210
[No Abstract] [Full Text] [Related]
7. Effect of a novel environment on locomotor hyperactivity of rats induced by apomorphine in the nucleus accumbens.
Morgenstern R; Fink H
Biomed Biochim Acta; 1985; 44(10):1517-22. PubMed ID: 4084255
[TBL] [Abstract][Full Text] [Related]
8. A demonstration of the ability of apomorphine to act on dopamine receptors on nerve terminals in the nucleus accumbens to reduce locomotor hyperactivity [proceedings].
Costall B; Hui SC; Naylor RJ
Br J Pharmacol; 1979 Nov; 67(3):475P-476P. PubMed ID: 497587
[No Abstract] [Full Text] [Related]
9. Destruction of 5-hydroxytryptaminergic neurons and the dynamics of dopamine in nucleus accumbens septi and other forebrain regions of the rat.
Lyness WH; Moore KE
Neuropharmacology; 1981 Apr; 20(4):327-34. PubMed ID: 6793886
[No Abstract] [Full Text] [Related]
10. Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat.
Kafetzopoulos E
Psychopharmacology (Berl); 1986; 88(3):271-4. PubMed ID: 3083447
[TBL] [Abstract][Full Text] [Related]
11. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat.
Van den Bos R; Cools AR; Ogren SO
Acta Physiol Scand; 1989 Dec; 137(4):547-8. PubMed ID: 2557730
[No Abstract] [Full Text] [Related]
12. Nucleus accumbens lesions reduce amphetamine hyperthermia but not hyperactivity.
Wirtshafter D; Asin KE; Kent EW
Eur J Pharmacol; 1978 Oct; 51(4):449-52. PubMed ID: 710513
[TBL] [Abstract][Full Text] [Related]
13. Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion.
Costall B; Domeney AM; Naylor RJ
Neuropharmacology; 1984 Mar; 23(3):287-94. PubMed ID: 6145111
[TBL] [Abstract][Full Text] [Related]
14. Septal lesions enhance hyperactivity induced either by amphetamine or lesions of the nucleus accumbens septi.
Carey RJ
Behav Brain Res; 1982 May; 5(1):43-52. PubMed ID: 7082466
[TBL] [Abstract][Full Text] [Related]
15. [The role of the globus pallidus (GP) and nucleus accumbens (NAc) in the control of avoidance conditioning of rats].
Mei ZT; Li DQ
Sheng Li Xue Bao; 1987 Jun; 39(3):220-6. PubMed ID: 3672138
[No Abstract] [Full Text] [Related]
16. The relationship between cholinergic and dopaminergic mechanisms in the nucleus accumbens for the control of locomotor activity [proceedings].
Costall B; Hui SC; Naylor RJ
Br J Pharmacol; 1979 May; 66(1):121P-122P. PubMed ID: 454917
[No Abstract] [Full Text] [Related]
17. Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity.
Van Ree JM; Wolterink G
Eur J Pharmacol; 1981 Jun; 72(1):107-11. PubMed ID: 7262189
[No Abstract] [Full Text] [Related]
18. Electrolytic lesions of the substantia innominata and lateral preoptic area attenuate the 'supersensitive' locomotor response to apomorphine resulting from denervation of the nucleus accumbens.
Swerdlow NR; Swanson LW; Koob GF
Brain Res; 1984 Jul; 306(1-2):141-8. PubMed ID: 6087974
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?
Costall B; Fortune DH; Hui SC; Naylor RJ
Eur J Pharmacol; 1980 May; 63(4):347-58. PubMed ID: 6104603
[No Abstract] [Full Text] [Related]
20. Behavioral evidence for the involvement of endogenous opioids in the interaction between cholecystokinin and brain dopamine systems.
Király I; Van Ree JM
Neurosci Lett; 1987 Mar; 74(3):343-7. PubMed ID: 3561887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
